Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy
Authors
Keywords
-
Journal
MEDICINAL RESEARCH REVIEWS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-02-12
DOI
10.1002/med.21568
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacology and in vivo efficacy of pyridine-pyrimidine amides that inhibit microtubule polymerization
- (2018) Adam Siddiqui-Jain et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A Convergence-Based Framework for Cancer Drug Resistance
- (2018) David J. Konieczkowski et al. CANCER CELL
- Automated identification of structurally heterogeneous and patentable antiproliferative hits as potential tubulin inhibitors
- (2018) Giuseppe Felice Mangiatordi et al. Chemical Biology & Drug Design
- Design, synthesis and anticancer evaluation of novel spirobenzo[ h ]chromene and spirochromane derivatives with dual EGFR and B-RAF inhibitory activities
- (2018) Shaimaa A. Abdelatef et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design and characterization of α -lipoic acyl shikonin ester twin drugs as tubulin and PDK1 dual inhibitors
- (2018) Hong-Yan Lin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, Cytotoxic Evaluation and Molecular Docking of New Fluoroquinazolinones as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects
- (2018) Mohamed Zayed et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Design and Development of Potent Small Molecules as Anticancer Agents Targeting EGFR TK and Tubulin Polymerization
- (2018) Saleh Ihmaid et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The compound millepachine and its derivatives inhibit tubulin polymerization by irreversibly binding to the colchicine-binding site in β-tubulin
- (2018) Jianhong Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Heterocyclic-Fused Pyrimidines as Novel Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site: Structural Basis and Antitumor Efficacy
- (2018) Souvik Banerjee et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel Dual Mechanism of Action Src Signaling and Tubulin Polymerization Inhibitors (KX2-391 and KX2-361)
- (2018) Michael P. Smolinski et al. JOURNAL OF MEDICINAL CHEMISTRY
- Microtubule dynamics: an interplay of biochemistry and mechanics
- (2018) Gary J. Brouhard et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Identification and characterization of SSE15206, a microtubule depolymerizing agent that overcomes multidrug resistance
- (2018) Safia Manzoor et al. Scientific Reports
- Design, synthesis and preclinical evaluation of 5-methyl-N4-aryl-furo[2,3-d]pyrimidines as single agents with combination chemotherapy potential
- (2018) Ravi Kumar Vyas Devambatla et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- First-in-human phase I study of the microtubule inhibitor plocabulin in patients with advanced solid tumors
- (2018) Elena Elez et al. INVESTIGATIONAL NEW DRUGS
- Consequences of mitotic slippage for antimicrotubule drug therapy
- (2017) Bing Cheng et al. ENDOCRINE-RELATED CANCER
- Novel chemotypes targeting tubulin at the colchicine binding site and unbiasing P-glycoprotein
- (2017) Giuseppe Felice Mangiatordi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A novel dual inhibitor of microtubule and Bruton's tyrosine kinase inhibits survival of multiple myeloma and osteoclastogenesis
- (2017) Manoj K. Pandey et al. EXPERIMENTAL HEMATOLOGY
- Microtubule Depolymerization by Kinase Inhibitors: Unexpected Findings of Dual Inhibitors
- (2017) Kenji Tanabe INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression
- (2017) Muralidharan Anbalagan et al. MOLECULAR CANCER RESEARCH
- Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects
- (2017) Mohamed Alswah et al. MOLECULES
- Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy
- (2017) Hao Chen et al. MOLECULES
- Mitotic progression following DNA damage enables pattern recognition within micronuclei
- (2017) Shane M. Harding et al. NATURE
- Cytoplasmic chromatin triggers inflammation in senescence and cancer
- (2017) Zhixun Dou et al. NATURE
- Deconvolution of Buparlisib’s mechanism of action defines specific PI3K and tubulin inhibitors for therapeutic intervention
- (2017) Thomas Bohnacker et al. Nature Communications
- Novel strategies to prevent the development of multidrug resistance (MDR) in cancer
- (2017) Jinglu Wang et al. Oncotarget
- Antitumor Effect of KX-01 through Inhibiting Src Family Kinases and Mitosis
- (2017) Seongyeong Kim et al. Cancer Research and Treatment
- Is inflammatory micronucleation the key to a successful anti-mitotic cancer drug?
- (2017) T. J. Mitchison et al. Open Biology
- Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site
- (2016) Xiaoxin Wu et al. Anti-Cancer Agents in Medicinal Chemistry
- 3-Cyano-6-(5-methyl-3-pyrazoloamino) pyridines (Part 2): A dual inhibitor of Aurora kinase and tubulin polymerization
- (2016) Masahiko Morioka BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Microtubule destabilising agents: far more than just antimitotic anticancer drugs
- (2016) Darcy Bates et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade
- (2016) Zhaolin Chen et al. CANCER LETTERS
- Small-molecule kinase inhibitors: an analysis of FDA-approved drugs
- (2016) Peng Wu et al. DRUG DISCOVERY TODAY
- Cancer chemoresistance; biochemical and molecular aspects: a brief overview
- (2016) Saeed Kachalaki et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- ABCG2 inhibition as a therapeutic approach for overcoming multidrug resistance in cancer
- (2016) Maryam Hosseini Hasanabady et al. JOURNAL OF BIOSCIENCES
- Characterizing the Epothilone Binding Site on β-Tubulin by Photoaffinity Labeling: Identification of β-Tubulin Peptides TARGSQQY and TSRGSQQY as Targets of an Epothilone Photoprobe for Polymerized Tubulin
- (2016) Adwait R. Ranade et al. JOURNAL OF MEDICINAL CHEMISTRY
- Colchicine to decrease NLRP3-activated inflammation and improve obesity-related metabolic dysregulation
- (2016) Andrew P. Demidowich et al. MEDICAL HYPOTHESES
- Current Advances of Tubulin Inhibitors in Nanoparticle Drug Delivery and Vascular Disruption/Angiogenesis
- (2016) Souvik Banerjee et al. MOLECULES
- Recent Advances in chemistry and pharmacology of 2-methoxyestradiol: An anticancer investigational drug
- (2016) B. Sathish Kumar et al. STEROIDS
- Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma
- (2016) Valerie B. Sampson et al. Oncotarget
- A Novel Nitrobenzoate Microtubule Inhibitor that Overcomes Multidrug Resistance Exhibits Antitumor Activity
- (2016) Yan-Bo Zheng et al. Scientific Reports
- Image-based compound profiling reveals a dual inhibitor of tyrosine kinase and microtubule polymerization
- (2016) Kenji Tanabe Scientific Reports
- The potential of Src inhibitors
- (2015) Daniel Elias et al. Aging-US
- The design, synthesis and biological evaluation of conformationally restricted 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multi-targeted receptor tyrosine kinase and microtubule inhibitors as potential antitumor agents
- (2015) Xin Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
- (2015) Lorenzo Galluzzi et al. CANCER CELL
- High affinity and covalent-binding microtubule stabilizing agents show activity in chemotherapy-resistant acute myeloid leukemia cells
- (2015) Benet Pera et al. CANCER LETTERS
- Identification of synthetic lethality of PLK1 inhibition and microtubule-destabilizing drugs
- (2015) M Hugle et al. CELL DEATH AND DIFFERENTIATION
- Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments
- (2015) Ya-Ting Ji et al. CURRENT MEDICINAL CHEMISTRY
- Anti-cancer chalcones: Structural and molecular target perspectives
- (2015) Debarshi Kar Mahapatra et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Taxane anticancer agents: a patent perspective
- (2015) Iwao Ojima et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery
- (2015) Yuxi Wang et al. FEBS Journal
- Bis-aryl Urea Derivatives as Potent and Selective LIM Kinase (Limk) Inhibitors
- (2015) Yan Yin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Colchicine—Update on mechanisms of action and therapeutic uses
- (2015) Ying Ying Leung et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Antitumour potential of BPT: a dual inhibitor of cdk4 and tubulin polymerization
- (2015) S Mahale et al. Cell Death & Disease
- Structural Optimization of Indole Derivatives Acting at Colchicine Binding Site as Potential Anticancer Agents
- (2015) Dong-Jin Hwang et al. ACS Medicinal Chemistry Letters
- LIM kinase inhibitors disrupt mitotic microtubule organization and impair tumor cell proliferation
- (2015) Katerina Mardilovich et al. Oncotarget
- Identification of DW532 as a novel anti-tumor agent targeting both kinases and tubulin
- (2014) Ting Peng et al. ACTA PHARMACOLOGICA SINICA
- Structural Basis of Microtubule Stabilization by Laulimalide and Peloruside A
- (2014) Andrea E. Prota et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Development of other microtubule-stabilizer families
- (2014) Cynthia F. Brogdon et al. ANTI-CANCER DRUGS
- PM060184, a new tubulin binding agent with potent antitumor activity including P-glycoprotein over-expressing tumors
- (2014) Marta Martínez-Díez et al. BIOCHEMICAL PHARMACOLOGY
- The design and discovery of water soluble 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multitargeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agents
- (2014) Xin Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function
- (2014) Jessica J. Field et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Movers and shakers: cell cytoskeleton in cancer metastasis
- (2014) C M Fife et al. BRITISH JOURNAL OF PHARMACOLOGY
- The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity
- (2014) Kea Martin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- High-Resolution Microtubule Structures Reveal the Structural Transitions in αβ-Tubulin upon GTP Hydrolysis
- (2014) Gregory M. Alushin et al. CELL
- Effects of the Tumor-Vasculature-Disrupting Agent Verubulin and Two Heteroaryl Analogues on Cancer Cells, Endothelial Cells, and Blood Vessels
- (2014) Katharina Mahal et al. ChemMedChem
- Recent developments in tubulin polymerization inhibitors: An overview
- (2014) Ramandeep Kaur et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The contribution of αβ-tubulin curvature to microtubule dynamics
- (2014) Gary J. Brouhard et al. JOURNAL OF CELL BIOLOGY
- Synthetic Reactions with Rare Taccalonolides Reveal the Value of C-22,23 Epoxidation for Microtubule Stabilizing Potency
- (2014) Jiangnan Peng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Optimization of 4-(N-Cycloamino)phenylquinazolines as a Novel Class of Tubulin-Polymerization Inhibitors Targeting the Colchicine Site
- (2014) Xiao-Feng Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Biological Evaluation of Novel Pyridine-Bridged Analogues of Combretastatin-A4 as Anticancer Agents
- (2014) Shilong Zheng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cytotoxic Effects of Fascaplysin against Small Cell Lung Cancer Cell Lines
- (2014) Gerhard Hamilton Marine Drugs
- The cGAS-cGAMP-STING Pathway of Cytosolic DNA Sensing and Signaling
- (2014) Xin Cai et al. MOLECULAR CELL
- Silencing of the ABCC4 gene by RNA interference reverses multidrug resistance in human gastric cancer
- (2014) GUANGYU ZHANG et al. ONCOLOGY REPORTS
- Ion channels and transporters in the development of drug resistance in cancer cells
- (2014) E. K. Hoffmann et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- A new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs
- (2014) A. E. Prota et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of a Type III Inhibitor of LIM Kinase 2 That Binds in a DFG-Out Conformation
- (2014) Nicole C. Goodwin et al. ACS Medicinal Chemistry Letters
- The role of dynamic instability in microtubule organization
- (2014) Tetsuya Horio et al. Frontiers in Plant Science
- Microtubule-Depolymerizing Agents Used in Antibody-Drug Conjugates Induce Antitumor Immunity by Stimulation of Dendritic Cells
- (2014) P. Muller et al. Cancer Immunology Research
- Cancer chemotherapy agents target intratumoral dendritic cells to potentiate antitumor immunity
- (2014) Philipp Müller et al. OncoImmunology
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- New Interfacial Microtubule Inhibitors of Marine Origin, PM050489/PM060184, with Potent Antitumor Activity and a Distinct Mechanism
- (2013) Benet Pera et al. ACS Chemical Biology
- Identification of novel compounds that enhance colon cancer cell sensitivity to inflammatory apoptotic ligands
- (2013) Avijeet S. Chopra et al. CANCER BIOLOGY & THERAPY
- A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer
- (2013) Emmanuel S. Antonarakis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Binding Sites of Microtubule-Stabilizing Agents
- (2013) Jessica J. Field et al. CHEMISTRY & BIOLOGY
- Tivantinib (ARQ197) Displays Cytotoxic Activity That Is Independent of Its Ability to Bind MET
- (2013) C. Basilico et al. CLINICAL CANCER RESEARCH
- P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives
- (2013) Ziyad Binkhathlan et al. CURRENT CANCER DRUG TARGETS
- Novel Piperazine-based Compounds Inhibit Microtubule Dynamics and Sensitize Colon Cancer Cells to Tumor Necrosis Factor-induced Apoptosis
- (2013) Avijeet Chopra et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of 4-Aryl-2-benzoyl-imidazoles as Tubulin Polymerization Inhibitor with Potent Antiproliferative Properties
- (2013) Min Xiao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Isolation and First Total Synthesis of PM050489 and PM060184, Two New Marine Anticancer Compounds
- (2013) María Jesús Martín et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Synergistic Combination of Novel Tubulin Inhibitor ABI-274 and Vemurafenib Overcomes Vemurafenib Acquired Resistance in BRAFV600E Melanoma
- (2013) J. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome
- (2013) Takuma Misawa et al. NATURE IMMUNOLOGY
- LIMK2 Mediates Resistance to Chemotherapeutic Drugs in Neuroblastoma Cells through Regulation of Drug-Induced Cell Cycle Arrest
- (2013) Cristina Gamell et al. PLoS One
- Tumor-Altered Dendritic Cell Function: Implications for Anti-Tumor Immunity
- (2013) Kristian M. Hargadon Frontiers in Immunology
- Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance
- (2012) Karthika Natarajan et al. BIOCHEMICAL PHARMACOLOGY
- Zampanolide, a Potent New Microtubule-Stabilizing Agent, Covalently Reacts with the Taxane Luminal Site in Tubulin α,β-Heterodimers and Microtubules
- (2012) Jessica J. Field et al. CHEMISTRY & BIOLOGY
- LIM kinase inhibition reduces breast cancer growth and invasiveness but systemic inhibition does not reduce metastasis in mice
- (2012) Rong Li et al. CLINICAL & EXPERIMENTAL METASTASIS
- Synthetic 2-Methoxyestradiol Derivatives: Structure-Activity Relationships
- (2012) Jean-Francois Peyrat et al. CURRENT MEDICINAL CHEMISTRY
- The Dual Role of Inflammation in Colon Carcinogenesis
- (2012) Giovanni Monteleone et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Discovery of Novel 2-Aryl-4-benzoyl-imidazole (ABI-III) Analogues Targeting Tubulin Polymerization As Antiproliferative Agents
- (2012) Jianjun Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Peptidomimetic Src/Pretubulin Inhibitor KX-01 Alone and in Combination with Paclitaxel Suppresses Growth, Metastasis in Human ER/PR/HER2-Negative Tumor Xenografts
- (2012) M. Anbalagan et al. MOLECULAR CANCER THERAPEUTICS
- Novel Tubulin Polymerization Inhibitors Overcome Multidrug Resistance and Reduce Melanoma Lung Metastasis
- (2012) Zhao Wang et al. PHARMACEUTICAL RESEARCH
- An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site
- (2012) Yan Lu et al. PHARMACEUTICAL RESEARCH
- FASCAPLYSIN as a Specific Inhibitor for CDK4: Insights from Molecular Modelling
- (2012) Muhammad Imtiaz Shafiq et al. PLoS One
- An Immunosurveillance Mechanism Controls Cancer Cell Ploidy
- (2012) L. Senovilla et al. SCIENCE
- Role of ABC transporters in cancer chemotherapy
- (2012) Yue-Li Sun et al. Chinese Journal of Cancer
- KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor α positive breast cancer
- (2011) Muralidharan Anbalagan et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase II Trial of Saracatinib (AZD0530), an Oral SRC-inhibitor for the Treatment of Patients with Hormone Receptor-negative Metastatic Breast Cancer
- (2011) Ayca Gucalp et al. Clinical Breast Cancer
- Cytokines, Inflammation and Colon Cancer
- (2011) L. Klampfer CURRENT CANCER DRUG TARGETS
- Molecular cytogenetic evaluation of the mechanism of genotoxic potential of amsacrine and nocodazole in mouse bone marrow cells
- (2011) Sabry M. Attia JOURNAL OF APPLIED TOXICOLOGY
- Differential Expression of NLRP3 among Hematopoietic Cells
- (2011) G. Guarda et al. JOURNAL OF IMMUNOLOGY
- Identification and Biological Activities of New Taccalonolide Microtubule Stabilizers
- (2011) Jiangnan Peng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Potent Taccalonolides, AF and AJ, Inform Significant Structure–Activity Relationships and Tubulin as the Binding Site of These Microtubule Stabilizers
- (2011) Jing Li et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Drugs that target dynamic microtubules: A new molecular perspective
- (2011) Richard A. Stanton et al. MEDICINAL RESEARCH REVIEWS
- Mitosis is not a key target of microtubule agents in patient tumors
- (2011) Edina Komlodi-Pasztor et al. Nature Reviews Clinical Oncology
- Current Status of Src Inhibitors in Solid Tumor Malignancies
- (2011) L. N. Puls et al. ONCOLOGIST
- What tubulin drugs tell us about microtubule structure and dynamics
- (2011) Linda A. Amos SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Aurora kinase inhibitors as anti-cancer therapy
- (2010) Warren Lok et al. ANTI-CANCER DRUGS
- Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy
- (2010) Phuong K. Morrow et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma
- (2010) R C DeConti et al. BRITISH JOURNAL OF CANCER
- KX-01, a Novel Src Kinase Inhibitor Directed towards the Peptide Substrate Site, Induces Robust Apoptosis and Synergizes with Tamoxifen and Chemotherapy in Breast Cancer.
- (2010) M. Anbalagan et al. CANCER RESEARCH
- Small-molecule inducer of cancer cell polyploidy promotes apoptosis or senescence: Implications for therapy
- (2010) Christian Tovar et al. CELL CYCLE
- p53-mediated transcriptional regulation and activation of the actin cytoskeleton regulatory RhoC to LIMK2 signaling pathway promotes cell survival
- (2010) Daniel R Croft et al. CELL RESEARCH
- New microtubule-inhibiting anticancer agents
- (2010) Si-Meng Chen et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Effect of aspirin and NSAIDs on risk and survival from colorectal cancer
- (2010) Farhat V N Din et al. GUT
- Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
- (2010) Joseph A. Sparano et al. JOURNAL OF CLINICAL ONCOLOGY
- Nanomedicinal strategies to treat multidrug-resistant tumors: current progress
- (2010) Xiaowei Dong et al. Nanomedicine
- Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy
- (2010) Klaus Strebhardt NATURE REVIEWS DRUG DISCOVERY
- Microtubule-binding agents: a dynamic field of cancer therapeutics
- (2010) Charles Dumontet et al. NATURE REVIEWS DRUG DISCOVERY
- Discovery of Dual VEGFR-2 and Tubulin Inhibitors with in Vivo Efficacy
- (2010) Eugene L. Piatnitski Chekler et al. ACS Medicinal Chemistry Letters
- Isocombretastatins A: 1,1-Diarylethenes as potent inhibitors of tubulin polymerization and cytotoxic compounds
- (2009) Raquel Álvarez et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Class III β-tubulin expression and in vitro resistance to microtubule targeting agents
- (2009) C Stengel et al. BRITISH JOURNAL OF CANCER
- Serum interleukin-6 levels in colorectal cancer patients—a summary of published results
- (2009) Heike Knüpfer et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- The Reversal of Drug-Resistance in Tumors Using a Drug-Carrying Nanoparticular System
- (2009) Kyung Oh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identification and Characterization of an Intermediate Taxol Binding Site Within Microtubule Nanopores and a Mechanism for Tubulin Isotype Binding Selectivity
- (2009) Holly Freedman et al. Journal of Chemical Information and Modeling
- Discovery and Development of Aurora Kinase Inhibitors as Anticancer Agents
- (2009) John R. Pollard et al. JOURNAL OF MEDICINAL CHEMISTRY
- LIM-kinase 2, a regulator of actin dynamics, is involved in mitotic spindle integrity and sensitivity to microtubule-destabilizing drugs
- (2009) S T Po'uha et al. ONCOGENE
- The Taccalonolides: Microtubule Stabilizers That Circumvent Clinically Relevant Taxane Resistance Mechanisms
- (2008) April L. Risinger et al. CANCER RESEARCH
- Stereoselective Synthesis of 3,3-Diarylacrylonitriles as Tubulin Polymerization Inhibitors
- (2008) Zhenglai Fang et al. JOURNAL OF ORGANIC CHEMISTRY
- Clinical Development of Ixabepilone and Other Epothilones in Patients with Advanced Solid Tumors
- (2008) E. Rivera et al. ONCOLOGIST
- Exploring the Mechanisms of Action of the Novel Microtubule Inhibitor Vinflunine
- (2008) Mary Ann Jordan et al. SEMINARS IN ONCOLOGY
- Inhibition of tubulin polymerization by select alkenyldiarylmethanes
- (2007) Matthew D. Cullen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started